Kingworld Medicines Group Ltd. ( (HK:1110) ) just unveiled an update.
Kingworld Medicines Group Limited has announced a board meeting scheduled for March 28, 2025, in Hong Kong. The meeting’s agenda includes reviewing and approving the audited annual results for the year ending December 31, 2024, and discussing the recommendation of a final dividend, which may impact the company’s financial strategy and shareholder returns.
More about Kingworld Medicines Group Ltd.
YTD Price Performance: -11.96%
Average Trading Volume: 714,618
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$245.6M
For a thorough assessment of 1110 stock, go to TipRanks’ Stock Analysis page.